Question 1

What is Cardinal Health's EV/EBITDA ratio?

Accepted Answer

Cardinal Health (CAH) EV/EBITDA ratio is 17.6× as of June 5, 2026. The ratio is calculated by dividing enterprise value by trailing twelve-month EBITDA, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the EV/EBITDA ratio calculated?

Accepted Answer

EV/EBITDA = Enterprise Value ÷ Trailing Twelve-Month (TTM) EBITDA, where Enterprise Value = Market Capitalisation + Total Debt − Cash & Short-Term Investments. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the EV/EBITDA ratio?

Accepted Answer

The EV/EBITDA ratio (the enterprise multiple) compares enterprise value (EV) to trailing twelve-month (TTM) EBITDA. EV is calculated as market capitalisation + total debt − cash & short-term investments. Because EV/EBITDA is capital-structure-neutral and ignores non-cash depreciation and amortisation, it is the standard multiple used in M&A and for cross-company or cross-border comparisons. Note: this calculation uses a simplified EV (minority interest and preferred equity excluded due to data availability), consistent with most public financial-data providers.

Question 4

What is a good EV/EBITDA ratio for Cardinal Health?

Accepted Answer

Mature, cash-generative businesses commonly trade in the 8–12× EV/EBITDA range; higher-growth, asset-light companies often trade at 15–25×+. EV/EBITDA is most useful for comparing companies with different capital structures (debt levels) or tax regimes. For Cardinal Health specifically, the relevant sector benchmark is the current sector median of 15.0×.

Question 5

Is Cardinal Health's EV/EBITDA ratio high or low?

Accepted Answer

Cardinal Health's EV/EBITDA ratio of 17.6× is below its own 5-year average of 29.4× and above the sector median of 15.0×. That places the current reading at the 67th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Cardinal Health's historical EV/EBITDA ratio range?

Accepted Answer

In the available daily series, Cardinal Health (CAH) EV/EBITDA ratio has ranged from a low of 5.9× in 2010 to a high of 302.9× in 2022. The 5-year average is 29.4× and the 5-year median is 15.5×.

Question 7

What was Cardinal Health's EV/EBITDA ratio in 2025?

Accepted Answer

Cardinal Health (CAH) EV/EBITDA ratio at the end of 2025 was 14.7×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month EBITDA figure available at that date.

Question 8

Why does Cardinal Health's EV/EBITDA ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (enterprise value, which tracks share price plus net debt) and the denominator (EBITDA). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$40.15B	$3.11B	14.7×	+2.2×	Jun 30, 2025
2024	$23.85B	$1.95B	12.5×	-4.9×	Jun 30, 2024
2023	$24.02B	$1.42B	17.3×	-189.2×	Jun 30, 2023
2022	$14.27B	$72.00M	206.5×	+191.4×	Jun 30, 2022
2021	$16.56B	$1.29B	15.1×	—	Jun 30, 2021
2020	$15.24B	−$2.62B	—	—	Jun 30, 2020
2019	$14.17B	$3.05B	6.5×	-13.3×	Jun 30, 2019
2018	$15.13B	$1.13B	19.7×	+9.8×	Jun 30, 2018
2017	$24.62B	$2.84B	9.9×	+0.7×	Jun 30, 2017
2016	$25.28B	$3.09B	9.2×	-1.9×	Jun 30, 2016
2015	$27.60B	$2.56B	11.1×	+0.9×	Jun 30, 2015
2014	$23.24B	$2.39B	10.2×	-2.7×	Jun 30, 2014
2013	$16.17B	$1.41B	12.9×	+5.7×	Jun 30, 2013
2012	$14.49B	$2.12B	7.1×	-1.5×	Jun 30, 2012
2011	$15.66B	$1.88B	8.6×	+1.8×	Jun 30, 2011
2010	$11.73B	$1.63B	6.8×	-1.3×	Jun 30, 2010
2009	$10.95B	$1.65B	8.1×	+0.1×	Jun 30, 2009
2008	$18.34B	$2.56B	8.0×	-7.0×	Jun 30, 2008
2007	$25.64B	$1.84B	15.1×	+3.2×	Jun 30, 2007
2006	$26.02B	$2.29B	11.9×	+1.3×	Jun 30, 2006
2005	$24.55B	$2.43B	10.6×	-1.7×	Jun 30, 2005
2004	$30.24B	$2.67B	12.3×	+0.7×	Jun 30, 2004
2003	$28.32B	$2.53B	11.6×	-0.8×	Jun 30, 2003
2002	$24.82B	$2.08B	12.4×	—	Jun 30, 2002


Gilead Sciences (GILD)	13.9×
Labcorp Holdings (LH)	13.6×
Amgen (AMGN)	13.6×
Charles River (CRL)	13.2×
Regeneron Pharmaceuticals (REGN)	12.9×
GE HealthCare (GEHC)	12.9×
UnitedHealth Group (UNH)	12.7×
Pfizer (PFE)	12.4×
Henry Schein (HSIC)	12.0×
Medtronic (MDT)	11.7×
AptarGroup (ATR)	11.5×
Bristol-Myers Squibb (BMY)	11.5×
Zimmer Biomet Holdings (ZBH)	11.2×
Biogen (BIIB)	10.5×
HCA Healthcare (HCA)	10.0×
Molina Healthcare (MOH)	8.8×
DaVita (DVA)	8.5×
IQVIA (IQV)	8.2×
Incyte (INCY)	7.9×
Cigna (CI)	7.8×
Elevance Health (ELV)	6.8×
Novo Nordisk (NVO)	6.5×
Solventum (SOLV)	5.8×
Universal Health Services (UHS)	5.7×
Humana (HUM)	4.5×

EV/EBITDA for Cardinal Health (CAH)

EV/EBITDA daily chart for Cardinal Health (CAH)

Historical EV/EBITDA for Cardinal Health (CAH) from 2002 to 2025

About EV/EBITDA at Cardinal Health (CAH)

Cardinal Health EV/EBITDA by Year

Cardinal Health EV/EBITDA 2025: 14.7×

Cardinal Health EV/EBITDA 2024: 12.5×

Cardinal Health EV/EBITDA 2023: 17.3×

Cardinal Health EV/EBITDA 2022: 206.5×

Cardinal Health EV/EBITDA 2021: 15.1×

Sector peers by EV/EBITDA — chart

Sector peers by EV/EBITDA — table

Frequently asked questions

Cardinal Health (CAH) Key Financials

EV/EBITDA daily chart for Cardinal Health (CAH)

Historical EV/EBITDA for Cardinal Health (CAH) from 2002 to 2025

About EV/EBITDA at Cardinal Health (CAH)

Cardinal Health EV/EBITDA by Year

Cardinal Health EV/EBITDA 2025: 14.7×

Cardinal Health EV/EBITDA 2024: 12.5×

Cardinal Health EV/EBITDA 2023: 17.3×

Cardinal Health EV/EBITDA 2022: 206.5×

Cardinal Health EV/EBITDA 2021: 15.1×

Sector peers by EV/EBITDA — chart

Sector peers by EV/EBITDA — table

Frequently asked questions

+What is Cardinal Health's EV/EBITDA ratio?

+How is the EV/EBITDA ratio calculated?

+What is the EV/EBITDA ratio?

+What is a good EV/EBITDA ratio for Cardinal Health?

+Is Cardinal Health's EV/EBITDA ratio high or low?

+What is Cardinal Health's historical EV/EBITDA ratio range?

+What was Cardinal Health's EV/EBITDA ratio in 2025?

+Why does Cardinal Health's EV/EBITDA ratio change over time?

Cardinal Health (CAH) Key Financials